Literature DB >> 21709021

A conditional mouse model for measuring the frequency of homologous recombination events in vivo in the absence of essential genes.

Adam D Brown1, Alison B Claybon, Alexander J R Bishop.   

Abstract

The ability to detect and repair DNA damage is crucial to the prevention of various diseases. Loss of function of genes involved in these processes is known to result in significant developmental defects and/or predisposition to cancer. One such DNA repair mechanism, homologous recombination, has the capacity to repair a wide variety of lesions. Knockout mouse models of genes thought to be involved in DNA repair processes are frequently lethal, making in vivo studies very difficult, if not impossible. Therefore, we set out to develop an in vivo conditional mouse model system to facilitate investigations into the involvement of essential genes in homologous recombination. To test our model, we measured the frequency of spontaneous homologous recombination using the pink-eyed unstable mouse model, in which we conditionally excised either Blm or full-length Brca1 (breast cancer 1, early onset). These two genes are hypothesized to have opposing roles in homologous recombination. In summary, our in vivo data supports in vitro studies suggesting that BLM suppresses homologous recombination, while full-length BRCA1 promotes this process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709021      PMCID: PMC3165555          DOI: 10.1128/MCB.00848-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Authors:  Y Jin; X L Xu; M C Yang; F Wei; T C Ayi; A M Bowcock; R Baer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.

Authors:  J M Gudas; T Li; H Nguyen; D Jensen; F J Rauscher; K H Cowan
Journal:  Cell Growth Differ       Date:  1996-06

Review 3.  The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH.

Authors:  M H Brilliant
Journal:  Pigment Cell Res       Date:  2001-04

Review 4.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 5.  Homologous recombination as a mechanism of carcinogenesis.

Authors:  A J Bishop; R H Schiestl
Journal:  Biochim Biophys Acta       Date:  2001-03-21

6.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Authors:  D Cortez; Y Wang; J Qin; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

7.  Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning.

Authors:  M H Brilliant; Y Gondo; E M Eicher
Journal:  Science       Date:  1991-04-26       Impact factor: 47.728

8.  Atm-, p53-, and Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development.

Authors:  Alexander J R Bishop; M Christine Hollander; Bela Kosaras; Richard L Sidman; Albert J Fornace; Robert H Schiestl
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

9.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Repairing a double-strand chromosome break by homologous recombination: revisiting Robin Holliday's model.

Authors:  James E Haber; Gregorz Ira; Anna Malkova; Neal Sugawara
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-01-29       Impact factor: 6.237

View more
  8 in total

1.  Induction of homologous recombination following in utero exposure to DNA-damaging agents.

Authors:  Bijal Karia; Jo Ann Martinez; Alexander J R Bishop
Journal:  DNA Repair (Amst)       Date:  2013-09-10

2.  Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis.

Authors:  Michael A McIlhatton; Kevin Murnan; Daniel Carson; Gregory P Boivin; Carlo M Croce; Joanna Groden
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-23

3.  A novel frameshift mutation in BLM gene associated with high sister chromatid exchanges (SCE) in heterozygous family members.

Authors:  Ghada Ben Salah; Ikhlas Hadj Salem; Abderrahmen Masmoudi; Fakhri Kallabi; Hamida Turki; Faiza Fakhfakh; Hamadi Ayadi; Hassen Kamoun
Journal:  Mol Biol Rep       Date:  2014-08-17       Impact factor: 2.316

4.  Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase.

Authors:  Elizabeth M Kass; Hildur R Helgadottir; Chun-Chin Chen; Maria Barbera; Raymond Wang; Ulrica K Westermark; Thomas Ludwig; Mary Ellen Moynahan; Maria Jasin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

5.  ATR suppresses endogenous DNA damage and allows completion of homologous recombination repair.

Authors:  Adam D Brown; Brian W Sager; Aparna Gorthi; Sonal S Tonapi; Eric J Brown; Alexander J R Bishop
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

Review 6.  Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer.

Authors:  Michael A Mcilhatton; Gregory P Boivin; Joanna Groden
Journal:  Biomed Res Int       Date:  2016-06-20       Impact factor: 3.411

7.  Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation.

Authors:  Elizabeth M Kass; Pei Xin Lim; Hildur R Helgadottir; Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Commun       Date:  2016-10-25       Impact factor: 14.919

8.  Double-strand break repair by interchromosomal recombination: an in vivo repair mechanism utilized by multiple somatic tissues in mammals.

Authors:  Ryan R White; Patricia Sung; C Greer Vestal; Gregory Benedetto; Noelle Cornelio; Christine Richardson
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.